Aerska is a biotechnology company pioneering RNA medicines to treat, delay, and prevent diseases of the brain.
Dublin-based Aerska, with research operations in London, is leveraging advances in ‘brain shuttles’ to enable targeted delivery of next-generation RNAi therapeutics to the CNS.
By silencing the genes that cause harm, Aerska aims to preserve the minds, protect the memories, and enable our loved ones to live longer, healthier lives.
Hi, we're Speedinvest
Proud partners with Europe's most visionary founders who are redefining technology's role in our daily lives.
Tell us about your startup.svg)
